Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab, Gemcitabine, and Oxaliplatin in Metastatic Pancreatic Cancer
NCT00112528Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Jun 2005
- Primary completion
- Aug 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in pancreatic adenocarcinoma (PDAC), sponsored by Cancer and Leukemia Group B. Started Jun 2005; status: completed.
02
Drugs
bevacizumab
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00112528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00112528.